About Othram
Othram is a company based in Houston (United States) founded in 2018 by David Mittelman. Othram has raised $33.16 million across 5 funding rounds from investors including Illumina and Gigafund. The company has 22 employees as of December 31, 2021. Othram operates in a competitive market with competitors including DDC Paternity Tests, Applied DNA Sciences, IntegenX, Arc Bio and ANDE, among others.
- Headquarter Houston, United States
- Employees 22 as on 31 Dec, 2021
- Founders David Mittelman
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Othram Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.16 M (USD)
in 5 rounds
-
Latest Funding Round
$6.56 M (USD), Series B
Feb 01, 2024
-
Investors
Illumina
& 1 more
-
Employee Count
22
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Othram
Unlock access to complete
Funding Insights of Othram
Othram has successfully raised a total of $33.16M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6.56 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Othram
Othram has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina and Gigafund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in multiple sectors
|
Locked | Locked | Locked | |
|
Developer of technologies for analysis of genetic variation and function
|
Locked | Locked | Locked |
Investor details for Othram
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Othram
Investment portfolio details for Othram
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Othram
Detailed financials for Othram
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Othram Comparisons
Peer comparison for Othram
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Othram
Othram operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DDC Paternity Tests, Applied DNA Sciences, IntegenX, Arc Bio and ANDE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| Locked | Locked | Locked |
Botanical-DNA-based security and authentication solutions are developed.
|
|
| Locked | Locked | Locked |
Instruments for rapid human DNA identification are developed.
|
|
| Locked | Locked | Locked |
Integrated genomics solutions are offered for forensics and infectious diseases.
|
|
| Locked | Locked | Locked |
Rapid DNA systems are provided for forensic identification and diagnostics.
|
Detailed competitors of Othram
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Othram
Complete news archive for Othram
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Othram
Othram was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Othram is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
David Mittelman is the current CEO of Othram. They have also founded this company.
Othram is a funded company, having raised a total of $33.16M across 5 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Othram is 22.
Othram was founded in 2018 and is based in Houston, United States. Operations focus on the genomics sector, where proprietary biomarkers are utilized to analyze genome profiles for forensic and investigative purposes. DNA is recovered from minimal samples through amplification techniques. Solutions are offered for identifying traits such as ancestry lineage, hair color, height, and genetic relatives by comparing genome sequences.
Othram's top competitors include DDC Paternity Tests, Key Forensic Services and Applied DNA Sciences.